Invesco Nasdaq Biotechnology ETF
$36.17$0.00 (0.0%)
Invesco Nasdaq Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
AMEX · NETL · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Colterpoint Net Lease Real Estate ETF’s quoted price sits in the lower half of its reported 52-week range, 16.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Colterpoint Net Lease Real Estate ETF’s forward annual dividend is $1.26 per share, paid monthly. The forward yield is 5.28% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
NETL is the first ETF on the market that focuses on the specific type of REIT, net lease real estate. A net lease is an arrangement that requires the tenant to pay all or a portion of the taxes, fees, and maintenance costs for a property in addition to rent. The fund will generally include US companies that derive at least 85% of their revenues from real estate operations in the net lease real estate sector. NETL will include securities of companies with both a diversified customer or tenant base and those generating more than half their revenue from a single customer or tenant. The Index caps the top five holdings at 8%, and the remainder at 4%, except for non-diversified companies, which are capped at 3.5% individually, and capped at 12.5% as a whole. The index is reconstituted and rebalanced quarterly. Prior to Oct. 14, 2025 the fund name was NETLease Corporate Real Estate ETF and index name was Fundamental Income Net Lease Real Estate TR Index.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:53 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$36.17$0.00 (0.0%)
Invesco Nasdaq Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$25.07-$0.20 (-0.79%)
Cambria Global Real Estate ETF’s quoted price sits in the lower half of its reported 52-week range, 14.5% below the high.
$36.76-$0.07 (-0.19%)
Cohen & Steers Natural Resources Active ETF’s quoted price sits in the upper half of its reported 52-week range, 6.74% below the high.
$32.14-$0.29 (-0.9%)
Pacer Swan SOS Conservative (October) ETF’s quoted price sits in the upper half of its reported 52-week range, 1.38% below the high.
$44.23-$0.52 (-1.15%)
Relative Sentiment Tactical Allocation ETF’s quoted price sits in the upper half of its reported 52-week range, 1.95% below the high.
$63.71-$0.28 (-0.44%)
AXS Knowledge Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 2.35% below the high.
$36.58-$0.85 (-2.27%)
Bridges Capital Tactical ETF’s quoted price sits in the upper half of its reported 52-week range, 4.85% below the high.
$27.60-$0.12 (-0.44%)
Day Hagan Smart Buffer ETF’s quoted price sits in the upper half of its reported 52-week range, 1.15% below the high.